The global tissue engineering market is anticipated to reach US$ 13,236.87 million in 2022 and is projected to touch US$ 29,659.93 million by 2028. It is expected to grow at a CAGR of 12.2% from 2022 to 2028.The growth of the global tissue engineering market is mainly attributed to factors, such as the increasing incidences of chronic diseases, road accidents and trauma injuries, and technological advancements in the field of 3D tissue engineering. However, the market is likely to get impacted by the high cost of treatments related to tissue engineering during the forecast period. Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, material methods, and appropriate biochemical and physicochemical factors to regenerate, preserve, enhance, or replace various types of biological tissues. Tissue Engineering (TE) is a rapidly evolving discipline that aims to repair, replace, or regenerate tissues or organs by converting fundamental physics, chemistry, and biology knowledge into practical and effective materials or devices and clinical strategies.
Tissue engineering has several primary functions in medicine and research: Assisting in tissue or organ repair, including bone repair (calcified tissue), cartilage tissue, heart tissue, pancreatic tissue, and vascular tissue. The field also researches the behavior of stem cells. Stem cells can develop into many different cell types and help repair areas of the body. The 3D nature of tissue engineering allows the study of tumor architecture in a more detailed environment. Tissue engineering also provides an environment to test potential new drugs for these diseases. The growth in the number of R&D activities with increasing awareness of tissue engineering in emerging markets is expected to support the global tissue engineering market growth. Developed nations have adopted technological advances in tissue engineering and regenerative medicine that contribute to expanding the global tissue engineering market.
Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. The COVID-19 pandemic has become the most significant challenge across the world. This challenge was frightening, especially in developing countries worldwide, as it expected to reduce imports due to disruptions in global trade in the coming years. To date, no definitive treatment against the COVID 19 has been established. Hence, the lack of definitive therapy offers significant opportunities for the tissue engineering market as the US FDA has recently approved the use of plasma therapy for critically ill COVID 19 patients.
Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system in managing the outbreak. The supply chain disruptions and the enormous demand for effective diagnostics and therapeutics for the treatment of COVID 19 put the healthcare research industry in a critical situation in various regions. Risks were majorly on emerging markets that face healthcare constraints and tighter financial conditions. The COVID-19 pandemic also hampered clinical trials, drug development, and the diagnostics industry's operation in the region.
Also, significant disruptions to routine research activities involving tissue engineering and regenerative medicines were observed due to the pandemic. Many industries were affected by the crisis, including tissue engineering research activities, due to the shutdown of research centers, lack of healthcare facilities, and an increasing number of cases. However, after the emergence of the COVID-19 vaccine, research centers have commenced studies and research on stem cells, regenerative medicine, and other therapies. Hence, the tissue engineering market in Europe is gaining attention after the COVID-19 impact.
Based on material type, the global tissue engineering market is segmented into synthetic material, biologically derived materials, and others. In 2022, the biologically derived materials segment is anticipated to account for the highest share of the global tissue engineering market. A biomaterial plays a significant role in the development of tissue engineering and biomedical devices that naturally increase the regenerative potential of tissues to restore body mechanisms in a state of deterioration.
Biologically derived materials are used in creating neo-tissues in vitro that are identical to their fundamental body parts. These materials also help in tissue regeneration by a controlled presentation and on-demand release of specific chemokines at injury sites, tissue-resembling structural, temporary biodegradable support matrices with natural and functional characteristics. However, the synthetic material segment is likely to register the highest CAGR in the global tissue engineering market during the forecast period.
Based on application, the global tissue engineering market is segmented into orthopedic, musculoskeletal & spine, neurology, cardiology and vascular, skin & integumentary, urology, GI & gynecology, cancer, and others. The orthopedic, musculoskeletal & spine segment is expected to lead the market in 2022. However, the skin & integumentary segment is anticipated to register the highest CAGR in the global tissue engineering market during the forecast period.
The World Health Organization (WHO), the US Food and Drug Administration (FDA), Centers For Disease Control And Prevention, American Heart Association, Biomedical Advanced Research and Development Authority, and Foundation For Innovative New Diagnostics are some of the major primary and secondary sources referred for preparing this report.
Tissue engineering has several primary functions in medicine and research: Assisting in tissue or organ repair, including bone repair (calcified tissue), cartilage tissue, heart tissue, pancreatic tissue, and vascular tissue. The field also researches the behavior of stem cells. Stem cells can develop into many different cell types and help repair areas of the body. The 3D nature of tissue engineering allows the study of tumor architecture in a more detailed environment. Tissue engineering also provides an environment to test potential new drugs for these diseases. The growth in the number of R&D activities with increasing awareness of tissue engineering in emerging markets is expected to support the global tissue engineering market growth. Developed nations have adopted technological advances in tissue engineering and regenerative medicine that contribute to expanding the global tissue engineering market.
Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. The COVID-19 pandemic has become the most significant challenge across the world. This challenge was frightening, especially in developing countries worldwide, as it expected to reduce imports due to disruptions in global trade in the coming years. To date, no definitive treatment against the COVID 19 has been established. Hence, the lack of definitive therapy offers significant opportunities for the tissue engineering market as the US FDA has recently approved the use of plasma therapy for critically ill COVID 19 patients.
Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system in managing the outbreak. The supply chain disruptions and the enormous demand for effective diagnostics and therapeutics for the treatment of COVID 19 put the healthcare research industry in a critical situation in various regions. Risks were majorly on emerging markets that face healthcare constraints and tighter financial conditions. The COVID-19 pandemic also hampered clinical trials, drug development, and the diagnostics industry's operation in the region.
Also, significant disruptions to routine research activities involving tissue engineering and regenerative medicines were observed due to the pandemic. Many industries were affected by the crisis, including tissue engineering research activities, due to the shutdown of research centers, lack of healthcare facilities, and an increasing number of cases. However, after the emergence of the COVID-19 vaccine, research centers have commenced studies and research on stem cells, regenerative medicine, and other therapies. Hence, the tissue engineering market in Europe is gaining attention after the COVID-19 impact.
Based on material type, the global tissue engineering market is segmented into synthetic material, biologically derived materials, and others. In 2022, the biologically derived materials segment is anticipated to account for the highest share of the global tissue engineering market. A biomaterial plays a significant role in the development of tissue engineering and biomedical devices that naturally increase the regenerative potential of tissues to restore body mechanisms in a state of deterioration.
Biologically derived materials are used in creating neo-tissues in vitro that are identical to their fundamental body parts. These materials also help in tissue regeneration by a controlled presentation and on-demand release of specific chemokines at injury sites, tissue-resembling structural, temporary biodegradable support matrices with natural and functional characteristics. However, the synthetic material segment is likely to register the highest CAGR in the global tissue engineering market during the forecast period.
Based on application, the global tissue engineering market is segmented into orthopedic, musculoskeletal & spine, neurology, cardiology and vascular, skin & integumentary, urology, GI & gynecology, cancer, and others. The orthopedic, musculoskeletal & spine segment is expected to lead the market in 2022. However, the skin & integumentary segment is anticipated to register the highest CAGR in the global tissue engineering market during the forecast period.
The World Health Organization (WHO), the US Food and Drug Administration (FDA), Centers For Disease Control And Prevention, American Heart Association, Biomedical Advanced Research and Development Authority, and Foundation For Innovative New Diagnostics are some of the major primary and secondary sources referred for preparing this report.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Tissue Engineering Market - By Material Type
1.3.2 Global Tissue Engineering Market - By Application
1.3.3 Global Tissue Engineering Market - By Geography
2. Tissue Engineering Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Tissue Engineering - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion
5. Global Tissue Engineering Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Number of Road Accidents and Trauma Injuries, and Elevating Incidence of Chronic Diseases
5.1.2 Technological Advancements in the Field of 3D Tissue Engineering
5.2 Key Market Restraints
5.2.1 High Cost of Treatment Options Involving Tissue Engineering
5.3 Key Market Opportunities
5.3.1 Growth in the Global Healthcare Market
5.4 Future Trends
5.4.1 Rapid Advancements in Regenerative Medicine
5.5 Impact Analysis
6. Tissue Engineering Market - Global Analysis
6.1 Global Tissue Engineering Market Revenue Forecast and Analysis
6.1.1 Global Tissue Engineering Market, By Geography - Forecast and Analysis
6.1.2 Global Tissue Engineering Market - Market Potential Analysis, By Region
6.1.3 Market Share Analysis of Tissue Engineering Market
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance Of Key Players
6.2.4.1 Zimmer Biomet
6.2.4.2 B. Braun Melsungen AG
7. Tissue Engineering Market Analysis - By Material Type
7.1 Overview
7.2 Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)
7.3 Synthetic Material
7.3.1 Overview
7.3.2 Synthetic Material: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Biologically Derived Materials
7.4.1 Overview
7.4.2 Biologically Derived Materials: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8. Tissue Engineering Market - By Application
8.1 Overview
8.2 Tissue Engineering Market, by Application, 2022 and 2028 (%)
8.3 Orthopedic, Musculoskeletal & Spine
8.3.1 Overview
8.3.2 Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Cardiology & Vascular
8.5.1 Overview
8.5.2 Cardiology & Vascular: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Skin & Integumentary
8.6.1 Overview
8.6.2 Skin & Integumentary: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Cancer
8.7.1 Overview
8.7.2 Cancer: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.8 GI & Gynaecology
8.8.1 Overview
8.8.2 GI & Gynaecology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.9 Urology
8.9.1 Overview
8.9.2 Urology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9. Tissue Engineering Market - Geographic Analysis
9.1 North America: Tissue Engineering Market
9.1.1 Overview
9.1.2 North America: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.4 North America Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.5 North America: Tissue Engineering Market, by Country, 2022 & 2028 (%)
9.1.5.1 US: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 US: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.2 US Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.3 US Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2 Canada: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Canada: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.2 Canada Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.3 Canada Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3 Mexico: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Mexico: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.2 Mexico Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.3 Mexico Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2 Europe: Tissue Engineering Market
9.2.1 Overview
9.2.2 Europe: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.2.4 Europe Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5 Europe: Tissue Engineering Market, by Country, 2022 & 2028 (%)
9.2.5.1 Germany: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Germany: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.2 Germany Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2 UK: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3 UK: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 UK Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.2 UK Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4 France: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5 France: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 France Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.2 France Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6 Spain: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Spain: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.2 Spain Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Spain Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.7 Italy: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.7.1 Italy: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.7.2 Italy Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.2.5.7.3 Italy Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.8 Rest of Europe: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.8.1 Rest of Europe: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.8.2 Rest of Europe Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.2.5.8.3 Rest of Europe Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.3 Asia Pacific: Tissue Engineering Market
9.3.1 Overview
9.3.2 Asia Pacific: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia Pacific Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.3.4 Asia Pacific Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.3.5 Asia Pacific: Tissue Engineering Market, by Country, 2022 & 2028 (%)
9.3.5.1 China: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.1 China: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.2 China Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.3 China Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2 Japan: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.1 Japan: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.2 Japan Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.3 Japan Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3 India: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.1 India: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.2 India Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.3 India Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4 South Korea: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 South Korea: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.2 South Korea Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.3 South Korea Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5 Australia: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Australia: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.2 Australia Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.3 Australia Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6 Rest of Asia Pacific: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Rest of Asia Pacific: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.2 Rest of Asia Pacific Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia Pacific Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.4 Middle East & Africa: Tissue Engineering Market
9.4.1 Overview
9.4.2 Middle East & Africa: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.4.4 Middle East & Africa Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.4.5 Middle East & Africa: Tissue Engineering Market Share by Country - 2022 & 2028, (%)
9.4.5.1 Saudi Arabia: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.1 Saudi Arabia: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.2 Saudi Arabia Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.4.5.1.3 Saudi Arabia Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.4.5.2 UAE: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.1 UAE: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.2 UAE Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.4.5.2.3 UAE Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.4.5.3 South Africa: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.1 South Africa: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.2 South Africa Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.4.5.3.3 South Africa Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.4.5.4 Rest of Middle East & Africa: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.1 Rest of Middle East & Africa: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.2 Rest of Middle East & Africa Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.4.5.4.3 Rest of Middle East & Africa Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.5 South and Central America: Tissue Engineering Market
9.5.1 Overview
9.5.2 South and Central America: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.5.3 South and Central America Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.5.4 South and Central America Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.5.5 South and Central America: Tissue Engineering Market, by Country, 2022 & 2028 (%)
9.5.5.1 Brazil: - Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.1 Brazil: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.2 Brazil Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.3 Brazil Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.5.5.2 Argentina: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.1 Argentina: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.2 Argentina Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.3 Argentina Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.5.5.3 Rest of South and Central America: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.1 Rest of South and Central America: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.2 Rest of South and Central America Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.3 Rest of South and Central America Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10. Impact of COVID-19 Pandemic on Global Tissue Engineering Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South & Central America: Impact assessment of COVID-19 Pandemic
11. Tissue Engineering Market - Industry Landscape
11.1 Growth Strategies Done by the Companies in the Market, 2121-2028
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Zimmer Biomet
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 B. Braun Melsungen AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Stryker Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AbbVie, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Integra LifeSciences Holdings Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Organogenesis Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Medtronic
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Baxter International Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Johnson and Johnson Services, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 3M
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Cook Biotech Inc.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Stryker Corporation
- Organogenesis Inc.
- Cook Biotech Inc.
- Integra Life Sciences Corporation
- 3M
- AbbVie Inc.
- Medtronic
- Zimmer Biomet
- Baxter International Inc.
- DePuy Synthes (Johnson & Johnson Services, Inc.)
- B. Braun Melsungen
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 199 |
| Published | May 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( $ | $ 13236.87 million |
| Forecasted Market Value ( $ | $ 29659.93 million |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
